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Nanofibrous Bicomponent Scaffolds for the Dual Delivery of NGF and GDNF: Controlled Release of Growth Factors 
and their Biological Effects 
Chaoyu Liu, MinWang 
Department of Mechanical Engineering, The University of Hong Kong, Pokfulam Road, Hong Kong 
Introduction: Repairing severely injured peripheral 
nerves requires suitable devices for bridging the gap and 
guiding axon growth. Due to limited availability and 
donor site function loss for autografts, tissue engineering-
based therapy using nerve guide conduits is a promising 
alternative and hence scaffolds with desired physical, 
chemical and biological properties are needed. 
Electrospun nanofibrous scaffolds offer distinctive 
advantages in facilitating Schwann cell migration and 
neurite outgrowth [Wang HB, et al., Acta Biomaterialia, 
2010, 6:2970-78]. Nerve tissue regeneration can be 
enhanced by the local delivery of biological cues 
including nerve growth factor (NGF) and glial cell line-
derived growth factor (GDNF). Therefore, nanofibrous 
bicomponent scaffolds were electrospun for the controlled 
release of NGF and GDNF [Liu C, Wang M, MRS Fall 
Meeting, Boston, MA, 2013]. In this study, the dual 
delivery of NGF and GDNF from novel bicomponent 
scaffolds and their biological effects were investigated. 
Methods: Using dual-source dual-powder electrospinning 
(DSDP-ES) (Wang C, Wang M, J. Mater.Sci.-Mater.Med., 
2012, 23:2381-97) and emulsion electrospinning (E-ES), 
novel bicomponent scaffolds were made, encapsulating 
NGF in poly(D,L-lactic acid) (PDLLA) fibers and GDNF 
in poly(lactic-co-glycolic acid) (PLGA) fibers. PLGA 
emulsions (12 or 15% w/v) and PDLLA emulsions (15 or 
20% w/v) were used for fibers. The ratio of NGF/PDLLA 
fibers to GDNF/PLGA fibers in scaffolds were varied and 
the scaffolds made were designated as: (1) S1, S2, S3, S4 
and S5 for GDNF/PLGA (12%w/v) and NGF/PDLLA 
(15%w/v) scaffolds at the fiber ratio of 1:0, 0:1, 1:1, 1:2 
and 2:1; (2) S6, S7, S8, S9 and S10 for GDNF/PLGA 
(15%w/v) and NGF/PDLLA (20%w/v) scaffolds at the 
fiber ratio of 1:0, 0:1, 1:1, 1:2 and 2:1; (3) S11 for PLGA 
and S12 for PDLLA monocomponent scaffolds without 
growth factors (GFs). The morphological and structural 
properties of scaffolds were assessed using SEM and 
TEM. In vitro release behaviors of NGF and GDNF were 
studied using ELISA kit assay. For evaluating bioactivity 
of GFs, PC12 cells were cultured in DMEM at 37°C with 
5% CO2. After 1 day, culture medium was replaced with 
medium containing intact GFs or GFs released from 
monocomponent scaffolds and replenished every 2 days. 
For biological investigations, PC12 cells were seeded on 
scaffolds and cultured for up to 7 days. MTT assay was 
used for cell proliferation study.F-actin and neurofilament 
were stained at day 4 and 7 for investigating cell 
differentiation under confocal laser scanning microscopy 
(CLSM). Neurite length was measured using Image J. 
Results: Smooth GDNF/PLGA and NGF/PDLLA fibers 
with core-shell structures were produced via E-ES. 
Through DSDP-ES, both types of nanofibers were evenly 
distributed in bicomponent scaffolds and desirable fiber 
ratios (and hence GF ratios) could be achieved. NGF and 
GDNF could be successfully incorporated in fibers with 
encapsulation efficiency above 80%. In a 42-day test 
period, GFs released from mono- or bicomponent 
scaffolds showed a burst release withi 24 h, followed by a 
sustained release. Both NGF and GDNF from scaffolds 
with various fiber ratios exhibited similar release profiles 
but different release amounts(Fig.1). MTT results showed 
bicomponent scaffolds had significant enhancement in 
cell proliferation compared with the control (Fig.2). GF 
bioactivity evaluation showed that the differentiation 
percentage of PC12 cells in the release group (providing 
released GFs) were only slightly lower than that of the 
control (the intact GFs), indicating bioactivity of released 
NGF and GDNF were preserved at maximum. The 
biological investigations revealed that GF-containing 
scaffolds significantly enhanced cell differentiation in 
terms of neurite outgrowth and branching of PC12 cells. 
High GF release amounts led to higher differentiation 
levels (Fig.2). Synergetic effect of NGF and GDNF on 
cell differentiation occurred at the 2:1 ratio of 
NGF/PDLLA to GDNF/PLGA in bicomponent scaffolds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1. In vitro release profiles for bicomponent scaffolds 
(Above: NGF release; below: GDNF release). 
 
 
 
 
 
 
 
 
 
Fig.2. PC12 cell proliferation (left) and differentiation 
(right) on mono- and bicomponent scaffolds. 
Conclusions: Bicomponent scaffolds containing designed 
amounts of NGF and GDNF with good post-release 
bioactivity could be made via DSDP-ES with E-ES. 
Sustained release of both GFs could be achieved. 
Compared with the control, mono- and bicomponent 
scaffolds containing GF or GFs induced much enhanced 
PC12 cell differentiation. Furthermore, NGF and GDNF 
released from bicomponent scaffolds exhibited synergetic 
effect on cell differentiation at certain fiber ratio(s).  
